Search Medical Condition
Please enter condition
Please choose location

Montpellier cedex 05, France Clinical Trials

A listing of Montpellier cedex 05, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (134) clinical trials

Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer

OBJECTIVES: Primary - Evaluate the percentage of histologically healthy margins maintained during resection in women with breast cancer. Secondary - Evaluate local recurrence at 5 years. - Evaluate aesthetic results. - Evaluate quality of life using the QLQC30 and BR23 questionnaires. OUTLINE: This is a multicenter study. Patients undergo oncoplastic ...

Phase

0.0 miles

Learn More »

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

OBJECTIVES: Primary - Identify factors predictive of treatment failure in patients with solid tumors treated with epoetin beta while undergoing chemotherapy. Secondary - Evaluate the impact of achieving target hemoglobin levels (i.e., hemoglobin > 11 g/dL) after 8 weeks of treatment with epoetin beta. - Evaluate changes in hemoglobin levels ...

Phase N/A

0.0 miles

Learn More »

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ

OBJECTIVES: Primary - Estimate and compare local recurrence-free survival of women with ductal breast carcinoma in situ (DCIS) treated with breast-conserving surgery followed by whole breast irradiation with vs without a radiation tumor bed boost. Secondary - Compare relapse-free survival between the two arms. - Compare overall survival. - Compare ...

Phase

0.0 miles

Learn More »

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

OBJECTIVES: Primary - Determine the recommended dose of trastuzumab when given with cetuximab in patients with metastatic pancreatic cancer that progressed after gemcitabine-based chemotherapy. (Phase I) - Evaluate the objective response rate as assessed by RECIST criteria. (Phase II) Secondary - Evaluate the safety profile as assessed by NCI CTCAE ...

Phase

0.0 miles

Learn More »

Surgery in Treating Patients With Neuroblastoma

OBJECTIVES: - Evaluate the safety and efficacy of surgical treatment alone for stage II neuroblastoma without N-myc amplification (NMA). - Describe predictive factors of relapse and survival for stages I and II neuroblastoma without NMA treated by surgery alone. OUTLINE: Patients with localized resectable tumors undergo surgery. Postoperative evaluations are ...

Phase

0.0 miles

Learn More »

Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

OBJECTIVES: - Determine the 18-month survival rate of patients with metastatic renal cell carcinoma treated with allogeneic stem cell transplantation. - Determine the objective rate of response of patients treated with this regimen. - Determine post-transplant immunological reactions and recuperation of patients treated with this regimen. - Determine the antitumoral ...

Phase

0.0 miles

Learn More »

Intraoperative Radiotherapy After Local Recurrence in Breast Cancer

Currently, the rate of ipsilateral breast tumor recurrence (IBTR) after breast- conserving surgery and radiotherapy remains at 10% at 10 years to 15% at 20 years, respectively. IBTR is an independent predictor of poor survival with a 3 to 4.6 increased risk of cancer-related death. In a heterogeneous population, local ...

Phase

0.0 miles

Learn More »